Zydenar, an anti-impotence drug, to launch from Dec. 22.

Published: 2005-12-26 06:58:00

Updated: 2005-12-26 06:58:00

Zydenar, a 4th anti-impotence drug developed in the world by Dong-A, will be launched to the market from Dec. 22, which will be available under the physician's prescriptions at any pharmacies across the nation.

Dong-A said that the clinical study showed its excellent efficacy lasting for over...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK